These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8347442)

  • 1. Potassium channel activators in the management of ischaemic heart disease: a focus on nicorandil.
    Purcell H; Fox K
    Br J Clin Pract; 1993; 47(3):150-4. PubMed ID: 8347442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical use of potassium channel activators in angina pectoris: efficacy and tolerance].
    Specchia G; Marsico F; Micheletti T; Bona M
    Cardiologia; 1995 Dec; 40(12 Suppl 1):91-5. PubMed ID: 8998788
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.
    Krumenacker M; Roland E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S93-102. PubMed ID: 1282184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of action of various ATP-sensitive potassium channel openers.
    Grover GJ
    Cardiovasc Res; 1996 Jan; 31(1):177-9. PubMed ID: 8849605
    [No Abstract]   [Full Text] [Related]  

  • 5. Nicorandil for angina.
    Drug Ther Bull; 1995 Dec; 33(12):89-92. PubMed ID: 8777891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescribing for angina.
    Shetty K
    Practitioner; 1994 Jul; 238(1540):540-2. PubMed ID: 7937508
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic application of myocardial cytoprotection].
    Ribeiro C
    Rev Port Cardiol; 1994 Sep; 13(9):669-70. PubMed ID: 7818940
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-angina activity of potassium-channel activators].
    Chiariello M; Duilio C; Ambrosio G
    Cardiologia; 1993 Dec; 38(12 Suppl 1):459-63. PubMed ID: 8020048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
    Frampton J; Buckley MM; Fitton A
    Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [K-channel activators and cardioprotection].
    Specchia G; Marsico F; Laudisa ML
    Cardiologia; 1993 Dec; 38(12 Suppl 1):453-7. PubMed ID: 8020047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potassium channel activators: hemodynamic effects at the systemic and coronary level].
    Perrone Filardi P; Chiariello M
    Cardiologia; 1995 Dec; 40(12 Suppl 1):87-9. PubMed ID: 8998787
    [No Abstract]   [Full Text] [Related]  

  • 12. [Increase of potassium conductance and spontaneous electric activity in vitro: comparison of nicorandil and cicletanine].
    Dawodu AA; Schiariti M; Monti F; Lanti M; Giglio V; Terracciano CM; Puddu PE; Campa PP
    Cardiologia; 1992 Feb; 37(2):141-9. PubMed ID: 1534710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A symposium: A new treatment for angina pectoris and heart failure. October 17, 1987, San Francisco. Proceedings.
    Am J Cardiol; 1989 Jun; 63(21):1J-85J. PubMed ID: 2525318
    [No Abstract]   [Full Text] [Related]  

  • 14. [Successful treatment of intraoperative myocardial ischemia with nicorandil].
    Kawamura S; Hayashida M; Orii R; Sawamura S; Komatsu K; Ito N; Kuzumi E; Hanaoka K
    Masui; 1997 Apr; 46(4):531-7. PubMed ID: 9128027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nicorandil, a potassium channel agonist].
    Gerson C
    Soins; 1996 Nov; (610):61. PubMed ID: 9016185
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina.
    Edwards RJ; Redwood SR; Lambiase PD; Marber MS
    Eur Heart J; 2005 Mar; 26(6):598-606. PubMed ID: 15618027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP sensitive potassium channel openers are of potential benefit in ischaemic heart disease.
    Cavero I; Premmereur J
    Cardiovasc Res; 1994 Jan; 28(1):32-3. PubMed ID: 8111790
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolving Issues in the Treatment of Angina Pectoris. Nicorandil: The 1st Potassium-Channel Activator in Ischemic Heart Disease. Proceedings of an International Workshop. Taormina, Sicily, May 8-12, 1991.
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S1-108. PubMed ID: 1282167
    [No Abstract]   [Full Text] [Related]  

  • 19. Potassium channel activators in vasospastic angina.
    Lablanche JM; Bauters C; McFadden EP; Quandalle P; Bertrand ME
    Eur Heart J; 1993 Jul; 14 Suppl B():22-4. PubMed ID: 8370368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pinacidil but not nicorandil opens ATP-sensitive K+ channels and protects against simulated ischemia in rabbit myocytes.
    Critz SD; Liu GS; Chujo M; Downey JM
    J Mol Cell Cardiol; 1997 Apr; 29(4):1123-30. PubMed ID: 9160864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.